Early biochemical and radiographic response after one cycle of [ 177 Lu]Lu-PSMA I&T radioligand therapy in metastatic castration-resistant prostate cancer patients.

Wojciech CytawaRobin HendelBartłomiej TomasikFranz-Xaver WeinzierlThorsten BleyJacek JassemAndreas SchirbelAndreas K BuckRalph A BundschuhPhilipp E HartrampfRudolf A WernerConstantin Lapa

Published in: European journal of nuclear medicine and molecular imaging (2023)

Lu]Lu-PSMA I&T RLT was an indicator of overall progression and poor clinical outcome.

Keyphrases

cell therapy
stem cells
pet ct
end stage renal disease
ejection fraction
small cell lung cancer
squamous cell carcinoma
peritoneal dialysis
prognostic factors
patient reported outcomes
bone marrow
patient reported